Document Detail


Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial.
MedLine Citation:
PMID:  21836134     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
RATIONALE: To establish a new approach to investigate the physiological effects of obstructive sleep apnea (OSA), and to evaluate novel treatments, during a period of continuous positive airway pressure (CPAP) withdrawal.
OBJECTIVES: To determine the effects of CPAP withdrawal.
METHODS: Forty-one patients with OSA and receiving CPAP were randomized to either CPAP withdrawal (subtherapeutic CPAP), or continued CPAP, for 2 weeks. Polysomnography, sleepiness, psychomotor performance, endothelial function, blood pressure (BP), heart rate (HR), urinary catecholamines, blood markers of systemic inflammation, and metabolism were assessed.
MEASUREMENTS AND MAIN RESULTS: CPAP withdrawal led to a recurrence of OSA within a few days and a return of subjective sleepiness, but was not associated with significant deterioration of psychomotor performance within 2 weeks. Endothelial function, assessed by flow-mediated dilatation, decreased significantly in the CPAP withdrawal group compared with therapeutic CPAP (mean difference in change, -3.2%; 95% confidence interval [CI], -4.5, -1.9%; P < 0.001). Compared with continuing CPAP, 2 weeks of CPAP withdrawal was associated with a significant increase in morning systolic BP (mean difference in change, +8.5 mm Hg; 95% CI, +1.7, +15.3 mm Hg; P = 0.016), morning diastolic BP (mean difference in change, +6.9 mm Hg; 95% CI, +1.9, +11.9 mm Hg; P = 0.008), and morning HR (mean difference in change, +6.3 bpm, 95% CI, +0.4, +12.2 bpm; P = 0.035). CPAP withdrawal was associated with an increase in urinary catecholamines but did not lead to an increase in markers of systemic inflammation, insulin resistance, or blood lipids.
CONCLUSIONS: CPAP withdrawal usually leads to a rapid recurrence of OSA, a return of subjective sleepiness, and is associated with impaired endothelial function, increased urinary catecholamines, blood pressure, and heart rate. Thus the proposed study model appears to be suitable to evaluate physiological and therapeutic effects in OSA. Clinical trial registered with www.controlled-trials.com (ISRCTN93153804).
Authors:
Malcolm Kohler; Anne-Christin Stoewhas; Lisa Ayers; Oliver Senn; Konrad E Bloch; Erich W Russi; John R Stradling
Related Documents :
2812894 - Effect of heart rate increase on dorsal aortic flow before and after volume loading in ...
22263544 - Normal perfusion pressure breakthrough phenomenon: what still remains unknown.
7629334 - Isothermal anneal effect on leucite content in dental porcelains.
7285314 - Ventricular diastolic pressure-volume relations and the pericardium. effects of changes...
2743374 - Long-term treatment with transdermal clonidine in mild hypertension.
17955854 - Use of an injector for the ex-press mini glaucoma shunt.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American journal of respiratory and critical care medicine     Volume:  184     ISSN:  1535-4970     ISO Abbreviation:  Am. J. Respir. Crit. Care Med.     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-12-23     Completed Date:  2012-01-05     Revised Date:  2014-03-19    
Medline Journal Info:
Nlm Unique ID:  9421642     Medline TA:  Am J Respir Crit Care Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1192-9     Citation Subset:  AIM; IM    
Data Bank Information
Bank Name/Acc. No.:
ISRCTN/ISRCTN93153804
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Actigraphy
Biological Markers / blood
Blood Pressure / physiology
Continuous Positive Airway Pressure* / methods
Disorders of Excessive Somnolence / etiology
Endothelium, Vascular / physiopathology
Female
Heart Rate / physiology
Humans
Inflammation / blood
Insulin Resistance / physiology
Male
Middle Aged
Polysomnography
Psychomotor Performance
Recurrence
Sleep Apnea, Obstructive / physiopathology,  therapy*
Chemical
Reg. No./Substance:
0/Biological Markers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Autophagy: a core cellular process with emerging links to pulmonary disease.
Next Document:  The Progression of Chronic Obstructive Pulmonary Disease is Heterogeneous: The Experience of the BOD...